Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer

CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2021-03, Vol.13 (5), p.1165
Hauptverfasser: Xiao, Malina, Hasmim, Meriem, Lequeux, Audrey, Moer, Kris Van, Tan, Tuan Zea, Gilles, Christine, Hollier, Brett G, Thiery, Jean Paul, Berchem, Guy, Janji, Bassam, Noman, Muhammad Zaeem
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 1165
container_title Cancers
container_volume 13
creator Xiao, Malina
Hasmim, Meriem
Lequeux, Audrey
Moer, Kris Van
Tan, Tuan Zea
Gilles, Christine
Hollier, Brett G
Thiery, Jean Paul
Berchem, Guy
Janji, Bassam
Noman, Muhammad Zaeem
description CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines and with the major EMT marker Vimentin in triple-negative breast cancers (TNBC). We showed that CMTM6 is concomitantly overexpressed with PD-L1 in breast mesenchymal compared with the epithelial cells. Driving a mesenchymal phenotype in SNAI1-inducible MCF-7 cells (MCF-7 cells) increased both PD-L1 and CMTM6. CMTM6 silencing in MCF-7 cells partially reduced cell surface expression of PD-L1, indicating that a proportion of the PD-L1 on the surface of MCF-7 cells depends on CMTM6. We also found a positive correlation between CMTM3 and CMTM7 expression with EMT score in breast cancer cells, and with Vimentin in TNBC patients. Dual knockdown of CMTM6 and CMTM7 significantly decreased PD-L1 surface expression in MCF-7 cells, indicating that both CMTM6 and CMTM7 regulate the expression of PD-L1. This study highlights the importance of CMTM6 and CMTM7 in EMT-induced PD-L1 and suggests that EMT, CMTM6 or CMTM7 modulators can be combined with anti-PD-L1 in patients with highly aggressive breast cancer.
doi_str_mv 10.3390/cancers13051165
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7963182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2508581843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-d88f98106236585b370c3f42fb3e636e74b25b27e15601d15f1810b10bbab0903</originalsourceid><addsrcrecordid>eNpdktFvFCEQxjdGY5vaZ98MiS--rAVmYdkXEz1r2-QuGj2fCXCzd9Q99gq7l_S_l9urTS0h4SP8voFhpijeMvoRoKEXzgSHMTGggjEpXhSnnNa8lLKpXj7RJ8V5Src0DwBWy_p1cQKgKDBoTos_lzs_bLDzpiNDTxaYMLjN_TZvl9GE5AffB_IT12NnBkzk1xhb45D8-FrOGdl7Q2aL5UISE1aTqslNWI1ucvlAvkQ0aSCz6aVvilet6RKeP6xnxe9vl8vZdTn_fnUz-zwvXSXFUK6UahvFqOQghRIWauqgrXhrASVIrCvLheU1MiEpWzHRskzbPK2xtKFwVnw6xt2Ndosrh2GIptO76Lcm3uveeP3_SfAbve73um4kMMVzADgG6DyuUffRer3nk3HSY7fWxmmLmnOpNBeNrCG7PjxcG_u7EdOgtz457DoTsB9TxqgSiqnqgL5_ht72Ywz5Uw4UO9SJsUxdHCkX-5Qito8pMKoPHaCfdUB2vHua-SP_r97wF0koqwI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2501331711</pqid></control><display><type>article</type><title>Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer</title><source>Electronic Journals Library</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Xiao, Malina ; Hasmim, Meriem ; Lequeux, Audrey ; Moer, Kris Van ; Tan, Tuan Zea ; Gilles, Christine ; Hollier, Brett G ; Thiery, Jean Paul ; Berchem, Guy ; Janji, Bassam ; Noman, Muhammad Zaeem</creator><creatorcontrib>Xiao, Malina ; Hasmim, Meriem ; Lequeux, Audrey ; Moer, Kris Van ; Tan, Tuan Zea ; Gilles, Christine ; Hollier, Brett G ; Thiery, Jean Paul ; Berchem, Guy ; Janji, Bassam ; Noman, Muhammad Zaeem</creatorcontrib><description>CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines and with the major EMT marker Vimentin in triple-negative breast cancers (TNBC). We showed that CMTM6 is concomitantly overexpressed with PD-L1 in breast mesenchymal compared with the epithelial cells. Driving a mesenchymal phenotype in SNAI1-inducible MCF-7 cells (MCF-7 cells) increased both PD-L1 and CMTM6. CMTM6 silencing in MCF-7 cells partially reduced cell surface expression of PD-L1, indicating that a proportion of the PD-L1 on the surface of MCF-7 cells depends on CMTM6. We also found a positive correlation between CMTM3 and CMTM7 expression with EMT score in breast cancer cells, and with Vimentin in TNBC patients. Dual knockdown of CMTM6 and CMTM7 significantly decreased PD-L1 surface expression in MCF-7 cells, indicating that both CMTM6 and CMTM7 regulate the expression of PD-L1. This study highlights the importance of CMTM6 and CMTM7 in EMT-induced PD-L1 and suggests that EMT, CMTM6 or CMTM7 modulators can be combined with anti-PD-L1 in patients with highly aggressive breast cancer.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13051165</identifier><identifier>PMID: 33803139</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibodies ; Breast cancer ; Cell surface ; Chromosomes ; Correlation analysis ; Epithelial cells ; Flow cytometry ; Gene regulation ; Genotype &amp; phenotype ; Human health sciences ; Mesenchyme ; Oncologie ; Oncology ; PD-L1 protein ; Phenotypes ; Proteins ; Sciences de la santé humaine ; Snail protein ; Software ; Transcription ; Tumor cell lines ; Tumor cells ; Vimentin</subject><ispartof>Cancers, 2021-03, Vol.13 (5), p.1165</ispartof><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-d88f98106236585b370c3f42fb3e636e74b25b27e15601d15f1810b10bbab0903</citedby><cites>FETCH-LOGICAL-c465t-d88f98106236585b370c3f42fb3e636e74b25b27e15601d15f1810b10bbab0903</cites><orcidid>0000-0002-4157-6538 ; 0000-0003-0157-2257 ; 0000-0002-9763-0943 ; 0000-0001-6624-1593</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963182/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963182/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33803139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xiao, Malina</creatorcontrib><creatorcontrib>Hasmim, Meriem</creatorcontrib><creatorcontrib>Lequeux, Audrey</creatorcontrib><creatorcontrib>Moer, Kris Van</creatorcontrib><creatorcontrib>Tan, Tuan Zea</creatorcontrib><creatorcontrib>Gilles, Christine</creatorcontrib><creatorcontrib>Hollier, Brett G</creatorcontrib><creatorcontrib>Thiery, Jean Paul</creatorcontrib><creatorcontrib>Berchem, Guy</creatorcontrib><creatorcontrib>Janji, Bassam</creatorcontrib><creatorcontrib>Noman, Muhammad Zaeem</creatorcontrib><title>Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines and with the major EMT marker Vimentin in triple-negative breast cancers (TNBC). We showed that CMTM6 is concomitantly overexpressed with PD-L1 in breast mesenchymal compared with the epithelial cells. Driving a mesenchymal phenotype in SNAI1-inducible MCF-7 cells (MCF-7 cells) increased both PD-L1 and CMTM6. CMTM6 silencing in MCF-7 cells partially reduced cell surface expression of PD-L1, indicating that a proportion of the PD-L1 on the surface of MCF-7 cells depends on CMTM6. We also found a positive correlation between CMTM3 and CMTM7 expression with EMT score in breast cancer cells, and with Vimentin in TNBC patients. Dual knockdown of CMTM6 and CMTM7 significantly decreased PD-L1 surface expression in MCF-7 cells, indicating that both CMTM6 and CMTM7 regulate the expression of PD-L1. This study highlights the importance of CMTM6 and CMTM7 in EMT-induced PD-L1 and suggests that EMT, CMTM6 or CMTM7 modulators can be combined with anti-PD-L1 in patients with highly aggressive breast cancer.</description><subject>Antibodies</subject><subject>Breast cancer</subject><subject>Cell surface</subject><subject>Chromosomes</subject><subject>Correlation analysis</subject><subject>Epithelial cells</subject><subject>Flow cytometry</subject><subject>Gene regulation</subject><subject>Genotype &amp; phenotype</subject><subject>Human health sciences</subject><subject>Mesenchyme</subject><subject>Oncologie</subject><subject>Oncology</subject><subject>PD-L1 protein</subject><subject>Phenotypes</subject><subject>Proteins</subject><subject>Sciences de la santé humaine</subject><subject>Snail protein</subject><subject>Software</subject><subject>Transcription</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><subject>Vimentin</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdktFvFCEQxjdGY5vaZ98MiS--rAVmYdkXEz1r2-QuGj2fCXCzd9Q99gq7l_S_l9urTS0h4SP8voFhpijeMvoRoKEXzgSHMTGggjEpXhSnnNa8lLKpXj7RJ8V5Src0DwBWy_p1cQKgKDBoTos_lzs_bLDzpiNDTxaYMLjN_TZvl9GE5AffB_IT12NnBkzk1xhb45D8-FrOGdl7Q2aL5UISE1aTqslNWI1ucvlAvkQ0aSCz6aVvilet6RKeP6xnxe9vl8vZdTn_fnUz-zwvXSXFUK6UahvFqOQghRIWauqgrXhrASVIrCvLheU1MiEpWzHRskzbPK2xtKFwVnw6xt2Ndosrh2GIptO76Lcm3uveeP3_SfAbve73um4kMMVzADgG6DyuUffRer3nk3HSY7fWxmmLmnOpNBeNrCG7PjxcG_u7EdOgtz457DoTsB9TxqgSiqnqgL5_ht72Ywz5Uw4UO9SJsUxdHCkX-5Qito8pMKoPHaCfdUB2vHua-SP_r97wF0koqwI</recordid><startdate>20210309</startdate><enddate>20210309</enddate><creator>Xiao, Malina</creator><creator>Hasmim, Meriem</creator><creator>Lequeux, Audrey</creator><creator>Moer, Kris Van</creator><creator>Tan, Tuan Zea</creator><creator>Gilles, Christine</creator><creator>Hollier, Brett G</creator><creator>Thiery, Jean Paul</creator><creator>Berchem, Guy</creator><creator>Janji, Bassam</creator><creator>Noman, Muhammad Zaeem</creator><general>MDPI AG</general><general>Multidisciplinary Digital Publishing Institute (MDPI)</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>Q33</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4157-6538</orcidid><orcidid>https://orcid.org/0000-0003-0157-2257</orcidid><orcidid>https://orcid.org/0000-0002-9763-0943</orcidid><orcidid>https://orcid.org/0000-0001-6624-1593</orcidid></search><sort><creationdate>20210309</creationdate><title>Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer</title><author>Xiao, Malina ; Hasmim, Meriem ; Lequeux, Audrey ; Moer, Kris Van ; Tan, Tuan Zea ; Gilles, Christine ; Hollier, Brett G ; Thiery, Jean Paul ; Berchem, Guy ; Janji, Bassam ; Noman, Muhammad Zaeem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-d88f98106236585b370c3f42fb3e636e74b25b27e15601d15f1810b10bbab0903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Breast cancer</topic><topic>Cell surface</topic><topic>Chromosomes</topic><topic>Correlation analysis</topic><topic>Epithelial cells</topic><topic>Flow cytometry</topic><topic>Gene regulation</topic><topic>Genotype &amp; phenotype</topic><topic>Human health sciences</topic><topic>Mesenchyme</topic><topic>Oncologie</topic><topic>Oncology</topic><topic>PD-L1 protein</topic><topic>Phenotypes</topic><topic>Proteins</topic><topic>Sciences de la santé humaine</topic><topic>Snail protein</topic><topic>Software</topic><topic>Transcription</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><topic>Vimentin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiao, Malina</creatorcontrib><creatorcontrib>Hasmim, Meriem</creatorcontrib><creatorcontrib>Lequeux, Audrey</creatorcontrib><creatorcontrib>Moer, Kris Van</creatorcontrib><creatorcontrib>Tan, Tuan Zea</creatorcontrib><creatorcontrib>Gilles, Christine</creatorcontrib><creatorcontrib>Hollier, Brett G</creatorcontrib><creatorcontrib>Thiery, Jean Paul</creatorcontrib><creatorcontrib>Berchem, Guy</creatorcontrib><creatorcontrib>Janji, Bassam</creatorcontrib><creatorcontrib>Noman, Muhammad Zaeem</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>ProQuest Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiao, Malina</au><au>Hasmim, Meriem</au><au>Lequeux, Audrey</au><au>Moer, Kris Van</au><au>Tan, Tuan Zea</au><au>Gilles, Christine</au><au>Hollier, Brett G</au><au>Thiery, Jean Paul</au><au>Berchem, Guy</au><au>Janji, Bassam</au><au>Noman, Muhammad Zaeem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2021-03-09</date><risdate>2021</risdate><volume>13</volume><issue>5</issue><spage>1165</spage><pages>1165-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines and with the major EMT marker Vimentin in triple-negative breast cancers (TNBC). We showed that CMTM6 is concomitantly overexpressed with PD-L1 in breast mesenchymal compared with the epithelial cells. Driving a mesenchymal phenotype in SNAI1-inducible MCF-7 cells (MCF-7 cells) increased both PD-L1 and CMTM6. CMTM6 silencing in MCF-7 cells partially reduced cell surface expression of PD-L1, indicating that a proportion of the PD-L1 on the surface of MCF-7 cells depends on CMTM6. We also found a positive correlation between CMTM3 and CMTM7 expression with EMT score in breast cancer cells, and with Vimentin in TNBC patients. Dual knockdown of CMTM6 and CMTM7 significantly decreased PD-L1 surface expression in MCF-7 cells, indicating that both CMTM6 and CMTM7 regulate the expression of PD-L1. This study highlights the importance of CMTM6 and CMTM7 in EMT-induced PD-L1 and suggests that EMT, CMTM6 or CMTM7 modulators can be combined with anti-PD-L1 in patients with highly aggressive breast cancer.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33803139</pmid><doi>10.3390/cancers13051165</doi><orcidid>https://orcid.org/0000-0002-4157-6538</orcidid><orcidid>https://orcid.org/0000-0003-0157-2257</orcidid><orcidid>https://orcid.org/0000-0002-9763-0943</orcidid><orcidid>https://orcid.org/0000-0001-6624-1593</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-03, Vol.13 (5), p.1165
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7963182
source Electronic Journals Library; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central; PubMed Central Open Access
subjects Antibodies
Breast cancer
Cell surface
Chromosomes
Correlation analysis
Epithelial cells
Flow cytometry
Gene regulation
Genotype & phenotype
Human health sciences
Mesenchyme
Oncologie
Oncology
PD-L1 protein
Phenotypes
Proteins
Sciences de la santé humaine
Snail protein
Software
Transcription
Tumor cell lines
Tumor cells
Vimentin
title Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T06%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epithelial%20to%20Mesenchymal%20Transition%20Regulates%20Surface%20PD-L1%20via%20CMTM6%20and%20CMTM7%20Induction%20in%20Breast%20Cancer&rft.jtitle=Cancers&rft.au=Xiao,%20Malina&rft.date=2021-03-09&rft.volume=13&rft.issue=5&rft.spage=1165&rft.pages=1165-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13051165&rft_dat=%3Cproquest_pubme%3E2508581843%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2501331711&rft_id=info:pmid/33803139&rfr_iscdi=true